News

You are here

Novosanis develops UrNCollect TM for SelectMDx for Prostate Cancer IVD kit of MDxHealth
Approval of Colli-Pee for commercial use in the US
Novosanis, a medical device company based in Wijnegem Belgium, together with GeneFirst, a molecular diagnostic company based in Oxfordshire UK, announced CE Marking and launch of...
Novosanis will present its VAX-ID™ device platform during BioJapan

Pages